Your browser doesn't support javascript.
loading
Self-reported distress and problems after treatment for gynecological cancer - Correlation between a short screening tool and longer measures of anxiety/depression and health-related quality of life.
Skaali, Tone; Blomhoff, Rune; Lindemann, Kristina; Smeland, Sigbjørn; Bruheim, Kjersti; Seland, Mette; Thorsen, Lene.
  • Skaali T; Department of Clinical Service, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
  • Blomhoff R; Department of Behavioral Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Lindemann K; Department of Clinical Service, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
  • Smeland S; Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Bruheim K; Department of Gynecologic Cancer, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
  • Seland M; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Thorsen L; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Acta Obstet Gynecol Scand ; 103(2): 387-395, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37991142
INTRODUCTION: The National Comprehensive Cancer Network (NCCN) distress thermometer and problem list (DTPL) is a brief self-report screening measure for use in follow-up cancer care. The aims of this study were to explore the correlations between scores on the DTPL and scores on longer measures of anxiety/depression and health-related quality of life among women treated for gynecological cancer, and to define a cutoff score on the DT representing high levels of psychological distress in this patient group. MATERIAL AND METHODS: During outpatient visits, 144 women filled in the DTPL, the Hospital Anxiety and Depression Scale (HADS) and the RAND-36-Item Short Form Health Survey (RAND-36) between October 2019 and March 2020. We assessed the agreement between the DT-scores and the HADS scores, explored variables associated with high levels of distress on the DT, and studied the associations between DTPL-scores and scores of health-related quality of life (HRQoL) from RAND-36. RESULTS: In receiver operating characteristic curve analysis between the distress score from the DT and a HADS total score ≥15 (defining high levels of anxiety/depression symptoms), the area under the curve was 0.81 (95% CI: 0.74-0.89). Using a cutoff of ≥5 on the DT (scale 0-10), we found a balanced level of sensitivity (81%) and specificity (71%) towards a HADS total score of ≥15. The scores of distress and problems reported on the DTPL correlated significantly with the majority of HRQoL function scales from RAND-36. CONCLUSIONS: The NCCN DTPL can be used as a screening measure for self-reported distress and problems after treatment for gynecological cancer. A score of ≥5 on DT may indicate high level of anxiety/depression as measured by HADS. The tool may help identify patients in need of referral to supportive care and rehabilitation facilities.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Depresión / Neoplasias Límite: Female / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Depresión / Neoplasias Límite: Female / Humans Idioma: En Año: 2024 Tipo del documento: Article